Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Senin

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Calcified Tissue International|May 1, 1995
Appendicular cortical bone loss after age 65: sex-dependent event?D Maggio, R Pacifici, A Cherubini, et al.
Alzheimer Disease and Associated Disorders|October 15, 1998
Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?P Mecocci, A Cherubini, M Bregnocchi, et al.
Monographs on Atherosclerosis|January 1, 1986
Echotomographic extracranial carotid evaluation in amaurosis fugax, hemispheric TIA and stroke patientsU Senin, E Mannarino, A Susta, et al.
Thrombosis and Haemostasis|February 1, 1996
Hemostasis abnormalities in patients with vascular dementia and Alzheimer's diseaseD Mari, L Parnetti, R Coppola, et al.
Archives of Gerontology and Geriatrics|September 1, 1995
Dexamethasone suppression test in elderly patients with dementia of Alzheimer type, vascular dementia and stroke: a re-evaluation of its applicabilityL Parnetti, G Reboldi, C Santucci, et al.
Acta Psychiatrica Scandinavica|March 28, 2008
Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative typesM Caputo, R Monastero, E Mariani, et al.
Pharmacological Research Communications|May 1, 1986
Long term-effect of fenofibrate on lipoprotein level and composition in different types of genetic hyperlipidemiasG Baggio, A Gasparotto, G Ciuffetti, et al.
Journal of the American Geriatrics Society|March 1, 1995
Increased CSF pyruvate levels as a marker of impaired energy metabolism in Alzheimer's diseaseL Parnetti, A Gaiti, M Brunetti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1991
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical studyU Senin, G Abate, C Fieschi, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer diseaseF Licastro, L Parnetti, M C Morini, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Calcified Tissue International|May 1, 1995
Appendicular cortical bone loss after age 65: sex-dependent event?D Maggio, R Pacifici, A Cherubini, et al.
Alzheimer Disease and Associated Disorders|October 15, 1998
Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?P Mecocci, A Cherubini, M Bregnocchi, et al.
Monographs on Atherosclerosis|January 1, 1986
Echotomographic extracranial carotid evaluation in amaurosis fugax, hemispheric TIA and stroke patientsU Senin, E Mannarino, A Susta, et al.
Thrombosis and Haemostasis|February 1, 1996
Hemostasis abnormalities in patients with vascular dementia and Alzheimer's diseaseD Mari, L Parnetti, R Coppola, et al.
Archives of Gerontology and Geriatrics|September 1, 1995
Dexamethasone suppression test in elderly patients with dementia of Alzheimer type, vascular dementia and stroke: a re-evaluation of its applicabilityL Parnetti, G Reboldi, C Santucci, et al.
Acta Psychiatrica Scandinavica|March 28, 2008
Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative typesM Caputo, R Monastero, E Mariani, et al.
Pharmacological Research Communications|May 1, 1986
Long term-effect of fenofibrate on lipoprotein level and composition in different types of genetic hyperlipidemiasG Baggio, A Gasparotto, G Ciuffetti, et al.
Journal of the American Geriatrics Society|March 1, 1995
Increased CSF pyruvate levels as a marker of impaired energy metabolism in Alzheimer's diseaseL Parnetti, A Gaiti, M Brunetti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1991
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical studyU Senin, G Abate, C Fieschi, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer diseaseF Licastro, L Parnetti, M C Morini, et al.
Pageof 12